(Adnkronos) - Sono cinque gli elementi che legano l’innovazione al trattamento oncologico “la prevenzione, gli screening, l'assistenza, la ricerca e l'intelligenza artificiale. Credo che i ragazzi coinvolti in Fattore J avranno da dire la loro sull'intelligenza artificiale e credo che potrebbe essere un ulteriore elemento da utilizzare”. Così Carlo Nicora, direttore generale Istituto nazionale dei Tumori di Milano, in occasione della presentazione della nuova edizione di ‘Fattore J’, un'iniziativa di Johnson & Johnson e Fondazione mondo digitale Ets che mira a sensibilizzare le giovani generazioni sul valore dell’innovazione nel campo della salute. Nel 2024-2025, il progetto esplorerà come l'intelligenza artificiale sta trasformando la medicina del futuro.
Category
🗞
NewsTranscript
00:00What advice would you give to young people in need of treatment?
00:04Generally, young people don't know what health is or don't talk about it.
00:12Today, they will have the opportunity to meet other young people who have had the tumour,
00:17who have been treated, some healed, some still on this very difficult path.
00:22What is the best opportunity to have agents of change,
00:26to have young people who can then tell other young people what the disease means
00:31and what it means to prevent the disease.
00:34I believe that today is a very important day,
00:37Factory G is a wonderful project and we are proud that the Institute can be a partner.
00:42There are four elements, prevention, screening, assistance, research.
00:48These are all four elements that have innovation, pharmacological technology and tools within them.
00:54Let's add a fifth, artificial intelligence.
00:57I believe that artificial intelligence and these young people on artificial intelligence
01:01will have their say.
01:03I believe it could be an additional element to be exploited and used.